Thursday 27 September
08:30

"Thursday 27 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO27-1
08:30 - 10:15

Live demo

Moderators: David BERNARDINI (Gastro-enterologist) (Aubagne, France), Laurent HEYRIES (PHD) (Marseille, France), Mahmoud OMAR (Clinical Director) (Kuwait, Kuwait), Michel ROBASZKIEWICZ (France)
Experts: Marianna ARVANITAKI (Expert, Belgium), Marc BARTHET (JCD) (Expert, Marseille, France), Erwan BORIES (Expert, Marseille, France), Pierre DEPREZ (Expert, Brussels, Belgium), Marc GIOVANNINI (Chef) (Expert, Marseille, France), Fauze MALUF-FILHO (Expert, sao Paulo, Brazil), Horst NEUHAUS (Expert, Germany)
La grande salle
10:45

"Thursday 27 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO27-2
10:45 - 12:45

Live demo

Moderators: David BERNARDINI (Gastro-enterologist) (Aubagne, France), Laurent HEYRIES (PHD) (Marseille, France), Mahmoud OMAR (Clinical Director) (Kuwait, Kuwait), Michel ROBASZKIEWICZ (France)
Experts: Marianna ARVANITAKI (Expert, Belgium), Marc BARTHET (JCD) (Expert, Marseille, France), Erwan BORIES (Expert, Marseille, France), Pierre DEPREZ (Expert, Brussels, Belgium), Marc GIOVANNINI (Chef) (Expert, Marseille, France), Fauze MALUF-FILHO (Expert, sao Paulo, Brazil), Horst NEUHAUS (Expert, Germany)
La grande salle
13:45

"Thursday 27 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO27-3
13:45 - 15:45

Live demo

Moderators: David BERNARDINI (Gastro-enterologist) (Aubagne, France), Laurent HEYRIES (PHD) (Marseille, France), Mahmoud OMAR (Clinical Director) (Kuwait, Kuwait), Michel ROBASZKIEWICZ (France)
Experts: Marianna ARVANITAKI (Expert, Belgium), Marc BARTHET (JCD) (Expert, Marseille, France), Erwan BORIES (Expert, Marseille, France), Pierre DEPREZ (Expert, Brussels, Belgium), Marc GIOVANNINI (Chef) (Expert, Marseille, France), Fauze MALUF-FILHO (Expert, sao Paulo, Brazil), Horst NEUHAUS (Expert, Germany)
La grande salle
16:15

"Thursday 27 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO27-4
16:15 - 17:15

Live demo

Moderators: David BERNARDINI (Gastro-enterologist) (Aubagne, France), Laurent HEYRIES (PHD) (Marseille, France), Mahmoud OMAR (Clinical Director) (Kuwait, Kuwait), Michel ROBASZKIEWICZ (France)
Experts: Marianna ARVANITAKI (Expert, Belgium), Marc BARTHET (JCD) (Expert, Marseille, France), Erwan BORIES (Expert, Marseille, France), Pierre DEPREZ (Expert, Brussels, Belgium), Marc GIOVANNINI (Chef) (Expert, Marseille, France), Fauze MALUF-FILHO (Expert, sao Paulo, Brazil), Horst NEUHAUS (Expert, Germany)
La grande salle
17:15

"Thursday 27 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO27-5
17:15 - 18:30

Free paper session

Moderators: Erwan BORIES (Marseille, France), Mahmoud OMAR (Clinical Director) (Kuwait, Kuwait)
17:15 - 17:30 #16629 - CO01 EUS Guided Injection of Methylene Blue in the CBD as a salvage after failed ERCP.
CO01 EUS Guided Injection of Methylene Blue in the CBD as a salvage after failed ERCP.

We are reporting a case of failed ERCP for a patient with cholangitis complicating ampullary adenoma. EUS was used as salvage for cannulation of the CBD. After several trials of wire RDV, Methylene Blue was injected and the flow from the papilla could easily serve as guide for identification of the papillary orifice.

EUS guided injection of Methylene Blue could offer a safe and easy approach for identification of the ampullary orifice if ERCP fails as well as wire RDV.


Mohamed EL-NADY (Cairo, Egypt), Osama EBADA
17:30 - 17:45 #16635 - CO02 Endoscopic Biliary Drainage in Biliary and Pancreatic Cancers: Results and Associated Factors for 105 Cases.
CO02 Endoscopic Biliary Drainage in Biliary and Pancreatic Cancers: Results and Associated Factors for 105 Cases.

Endoscopic biliary drainage remains the standard palliative treatment in neoplastic biliary stenosis in patients not operated. The objective of our study is to retrospectively specify the results of this technique in our training, as well as the various factors associated with its failure or success.Materials and MethodsJanuary 2009 to September 2017,105 patients with biliary stenosis of neoplastic origin were included. Patients were divided into 3 groups:"A" for patients with proximal cholangiocarcinoma, group "B" for patients with pancreatic cancer, group "C" for patients with a calculocancer. Success was defined clinically by jaundice regression and biologically by decrease in bilirubinemia. Statistical analysis was performed by SPSS 20.0 software. In order to study the factors associated with the success of endoscopic biliary drainage,we used a binary logistic regression based on a varied and varied analysis. The factors studied were sex, age, the presence of metastases and endoscopic dilatation of the stenosis before prosthesis placement. ResultsThe mean age was 63 years +/- 10.3 with extremes ranging from 31 to 93 years and a sex ratio H / F of 1.3. The overall success was 76.2%. The comparative study of the success rate in the 3 groups showed a superiority of group B with a success rate of 84.3%, followed by group C with a success rate of 77.2%, then of group A with a success of 62.5%. In multivariate analysis, and by adjusting the studied parameters (age, sex, the presence of metastases and endoscopic dilatation of the stenosis before prosthesis placement), only the presence of metastases and the endoscopic dilatation of stenosis altered the success rate. Indeed, the presence of metastases increases the risk of failure (OR = 8.4, p = 0.001, 95% CI = [2.4-29.8]), and the endoscopic dilatation of the stenosis before placement. prosthesis significantly decreased the failure rate (OR = 0.05, p = 0.0001, CI (95%) = [0.013-0.19]). Conclusion: Our study confirms that the palliative treatment of neoplastic biliary stenosis by endoscopic drainage remains effective in case of pancreatic cancer, however the results are less satisfactory in cases of caclulocancer and cholangiocarcinoma. The presence of metastases appears to be significantly associated with failure of endoscopic biliary drainage, and endoscopic dilatation before prosthesis placement seems to be associated with its success. Further study with a larger sample is essential to verify these results.


Sara JAMAL (Rabat, Morocco), Hassan SEDDIK, Khaoula LOUBARIS, Hanae BOUTALLAKA, Ahmed BENKIRANE
17:45 - 18:00 #16634 - CO03 Endoscopic retrograde cholangiopancreatography in pathologylithiasis: What results in patients over the age of 75?
CO03 Endoscopic retrograde cholangiopancreatography in pathologylithiasis: What results in patients over the age of 75?

In front of an increasingly aging population, the ERCP raises the question ofbenefit in the elderly. So we set ourselves the goal of comparing ERCP results in lithiasis pathology in elderly patients respectively less and more than 75 years old. Patients and Methods: This is a retrospective descriptive and analytical study conducted over a periodfrom May 2002 to February 2017, including 846 patients with ERCP for a lithiasic pathology. We divided our patients into two groups: thegroup I for patients younger than 75 years, and group II for patients over 75 years old. A patient was said to be aged from 75 years old. We realisedinitially a descriptive study of the characteristics of the elderly population, followed by a comparative analytical study of the results between the two groups concerning thesuccess rate and the rate of complications. Results:The group of elderly subjects (group II) accounted for 12.3% of the population (n = 101), with an average age of 80.17 +/- 5.43 years and extremes ranging from 75 to 96 years, sex H / F ratio was 1.2. Of these patients, 67.3% had no surgical history significant (n = 68), 28.7% were cholecystectomized, and only 4% antecedent of endoscopic biliary sphincterotomy. 5% of patients were admitted for acute pancreatitis (n = 5) and 25.7% were in acute cholangitis (n = 26). Radiologically, the average diameter of the VBP was 15.2 +/- 4.2mm. Choledochal stones were found in 37.8% of patients (n = 38), a large calculus was found in 10.9% of patients (n = 11). An SBE has been performed in 94.1% of patients (n = 95). The vacuity of VBP was obtained in 61.4% of cases in the patient group aged, compared to 78.4% in group I (p <0.001), use of laborers additional endoscopy was 30.7% in group II, compared to 18.3% only in group I (p = 0.003). The overall success rate was 85.2% in group II, compared with 92.5% in group I (p = 0.012). The rate of early complications was 6.9% in the group of elderly subjects, compared to 6% in group I, with no statistically significant difference (p = 0.48). Conclusion:Although the overall success rate remains better in the young patient , the results of ERCP in lithiasis pathology in the patients aged over 75 years remainsatisfactory, with no statistically significant difference in terms of complicationsearly ERCP. This allows us to deduce that the ERCP keeps all its interestin the elderly subject. A follow-up cohort study in the elderly still remainsnecessary to have more objective results.


Sara JAMAL (Rabat, Morocco), Hassan SEDDIK, Hanae BOUTALLAKA, Khaoula LOUBARIS, Ahmed BENKIRANE
18:00 - 18:15 #16627 - CO04 A case of Endoscopic Ultrasound (EUS)-guided pancreatic duct puncture for difficult Wirsung cannulation in recurrent acute pancreatitis.
CO04 A case of Endoscopic Ultrasound (EUS)-guided pancreatic duct puncture for difficult Wirsung cannulation in recurrent acute pancreatitis.

We report a case of EUS guided puncture of the main pancreatic duct for difficult cannulation during endoscopic retrograde cholangiopancreatography (ERCP) in a patient with recurrent acute pancreatitis (RAP).

A 72-years-old female referred to our Gastroenterology Unit for RAP. She had not known allergies and family history was not significant. She did not take medications, non-smoker, not consumed alcohol, and denied taking illicit drugs. She was previously submitted to laparoscopic cholecystectomy for symptomatic cholelithiasis (2010).

Two years after cholecystectomy, she experienced the first episode of acute pancreatitis (AP) presenting with epigastric pain, nausea, fever and elevation of amylase and lipase. Magnetic resonance cholangiopancreatography (MRCP) revealed a mild dilation of the extrahepatic bile ducts (7 mm) with narrowing of the distal common bile duct and mild Wirsung duct dilatation. She was submitted to endoscopic biliary sphincterotomy via ERCP and no stones were extracted, but was detected papillitis. It was ruled out hereditary cause of pancreatitis. The serological tests did not show a previous infection.

In the following months for the recurrence of AP she was underwent EUS that showed dilation of the common bile duct (10 mm) and a further MRCP which visualized a low insertion of the cystic duct into the choledochus. In an episode plastic metal stent placement in the common bile duct has been reported without success on the symptoms.

For the recurrent symptoms it was decided to opacify the Wirsung duct that had never been possible to cannulate due to technical difficulties also after secretin test. After several failed attempts to pancreatic catheterization at ERCP, it was decided to inject contrast by means of EUS to visualize periampullary pancreatic duct. After transduodenal puncture of the pancreatic duct using an EUS-fine needle (22-gauge), pancreatogram was performed and with duodenoscope has been obtained pancreatic catheterization with rapid drainage of the contrast. It was performed pancreatic sphincterotomy and a 5F plastic stent was placed, removed after a month. Until now the patient experienced a good relief of symptoms.

Conclusions

In this case EUS allowed to carry out a difficult access to the pancreatic duct during ERCP in a patient suffering from recurrent pancreatitis, probably secondary to an intermittent defect in the drainage of the Wirsung duct for fibrosis at the level of the papilla (stenosing papillitis).


Alessia SANTINI (Siena, Italy), Ivano BIVIANO, Silvia RENTINI, Raffaele CHIECA, Elena GIANNI, Mario MARINI, Raffaele MACCHIARELLI
18:15 - 18:30 #16610 - CO05 PRE-TREATMENT RISK ASSESSMENT OF GIST WITH EUS-FNB: CORE NEEDLES RELIABILITY.
CO05 PRE-TREATMENT RISK ASSESSMENT OF GIST WITH EUS-FNB: CORE NEEDLES RELIABILITY.

Background: recurrence of non-metastatic GIST and need of adjuvant Imatinib are related to post-operative pathological evaluation. Pre-treatment risk factors are tumor diameter, mitotic rate and site (gastric vs non-gastric). EUS-guided tissue acquisition is the mainstay for diagnosis of GIST, unfortunately EUS-FNA does not reliably reflect GIST’s proliferation and size.

Aim: to investigate the EUS-FNB diagnostic yield for GIST and to evaluate whether EUS-FNB reflects prognostic criteria obtained from resected GISTs.

Methods: a prospectively maintained database was retrospectively reviewed to identify consecutive patients with surgically resected subepithelial lesions who received a diagnosis of GIST at a previous EUS-FNB with a 19 or 22G core-needle (EchoTip®ProCore™, Cook Medical). Size from EUS examinaton and mitotic/proliferative indexes obtained from EUS-FNB samples were compared with surgical specimens.

Results: 18 patients were enrolled (11 males; mean age 71.6 years, range 44–88 yo). Tumour site was the stomach in 15/18 and duodenum in 3/18 patients. Agreement between EUS-FNB and surgical pathology was 100% with respect to the diagnosis of GIST (18/18). Proliferative indexes (Ki67/MIB1) were ratable in 14/18 (77.7%) of biopsies versus all cases of resected specimens and they were generally understimated. In 2/18 patients mitotic count was feasible (HPF>50) showing a mitotic index <5/50 HPFs confirmed by surgical specimens. In 16/18 patients no mitotic figures were observed in core biopsy specimen (1-22 HPF) whereas surgical specimens allowed to observe mitoses from 1 to 5 per 50HPF. Tumour size of the surgical specimen differed (>5 mm) EUS estimation in 12/18 subjects (66.6%) whereas it was comparable (± 5 mm) in 6/18 cases (33.3%). 

Conclusions: EUS-FNB have an extremely high diagnostic accuracy for GIST, however it underestimates proliferation indexes and rarely allows a reliable mitotic count mainly due to uneven distribution of the mitotic figures throughout the lesion. Furthermore, EUS generally underestimates the size of the lesions; this limit is linked to the “bidimensional” evaluation of lesions obtained by ultrasound. Our data obtained with EUS-FNB are similar to previous studies with FNA and constitute a major limitation for developing a possible pre-treatment and biopsy-based risk classification of GIST. Alternative parameters (genotype profiling) must be validated on pre-surgical biopsy samples from GISTs for prognostic purposes.

 


Roberto GRASSIA, Pietro CAPONE, Fabrizio CEREATTI (Cremona, Italy), Giulia Paola TANZI, Martinotti MARIO, Federico BUFFOLI
La grande salle
Friday 28 September
08:00

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-6
08:00 - 10:00

Session Pancreas

Moderators: Marianna ARVANITAKI (Belgium), Marc GIOVANNINI (Chef) (Marseille, France)
08:00 - 08:30 EUS-FNA or FNB? From diagnosis to tumor profiling. Juan IOVANNA (Keynote Speaker, Marseille, France)
08:30 - 09:00 Pancreatic Adenocarcinoma. Preoperative biliary drainage: whom ans how? Pierre DEPREZ (Keynote Speaker, Brussels, Belgium)
09:00 - 09:30 Branch Duct IPMN: Who to treat? and how to follow? Erwan BORIES (Keynote Speaker, Marseille, France)
09:30 - 10:00 Pancreatic neuroendocrine tumor: treatment in 2018. Patricia NICCOLI (Keynote Speaker, Marseille, France)
La grande salle
10:30

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-7
10:30 - 12:00

Video Session: How I perform

Moderators: Marianna ARVANITAKI (Belgium), Pierre DEPREZ (Brussels, Belgium), Mahmoud OMAR (Clinical Director) (Kuwait, Kuwait)
10:30 - 10:50 How I perform a EUS guided pancreatic RFA. Marc GIOVANNINI (Chef) (Keynote Speaker, Marseille, France)
10:50 - 11:10 How I perform a EUS guided gastroentero anastomosis. Marc BARTHET (JCD) (Keynote Speaker, Marseille, France)
11:10 - 11:40 How I perform a biliary drainage in altered anatomy. Fauze MALUF-FILHO (Keynote Speaker, sao Paulo, Brazil)
11:40 - 12:00 How I perform the endoscopic resection of a GI NET. Horst NEUHAUS (Keynote Speaker, Germany)
La grande salle
12:00

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-8b
12:00 - 12:30

sponsored session - ASPRO STUDY

12:00 - 12:30 Final results A multicentre randomized trial comparing a 25G EUS fine needle aspiration device with a novel 20G EUS fine needle biopsy device. Priscilla VAN RIET (Presenter, The Netherlands)
La grande salle
13:15

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-8c
13:15 - 14:00

Pentax Symposium

Moderators: Marc GIOVANNINI (Chef) (Marseille, France), Horst NEUHAUS (Germany)
13:15 - 13:30 Duodenoscope-related infection in ERCP: Isolated cases or worldwide call to action? M. GOTZ (Presenter, Germany)
13:30 - 13:45 One year using disposable elevator: Our experience in challenging cases. M. MUTIGNANI (Presenter, Italy)
13:45 - 14:00 Experience with a new echoendoscope - changing biliopancreatic diagnosis and treatment? Marc BARTHET (JCD) (Presenter, Marseille, France)
La grande salle
14:00

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-8
14:00 - 14:30

Free paper session

Moderators: David BERNARDINI (Gastro-enterologist) (Aubagne, France), Christian PESENTI (Marseille, France)
14:00 - 14:15 #16630 - CO06 Multimodal label-free imaging for instantaneous gastro-intestinal cancer detection.
CO06 Multimodal label-free imaging for instantaneous gastro-intestinal cancer detection.

Conventional histopathology, currently the ‘gold-standard’ for pathological diagnosis of cancer, requires extensive sample preparations that are achieved within time scales that are not compatible with intra-operative situations where quick decisions must be taken. Providing to pathologists a close to real-time technology revealing tissue structures at the cellular level with histologic quality would provide an invaluable tool for surgery guidance with evident clinical benefit. Here, we specifically develop a stimulated Raman imaging based framework that demonstrates gastro-intestinal (GI) cancer detection of unprocessed human surgical specimens. The generated stimulated Raman histology (SRH) images combine chemical and collagen information to mimic haematoxylin, eosin and saffron (HES) staining. The attached figure shows an example of SRH image obtained in 50 minutes as compared to the standart HES image obtained in 24h. We report excellent agreements between SRH and HES images acquire on the same patients for healthy, pre-cancerous and cancerous colon and pancreas tissue sections. We also develop a novel fast SRH imaging modality that captures at the pixel level all the information necessary to provide instantaneous SRH images. These developments pave the way for instantaneous label free GI histology in an intra-operative context.

Figure label: SRH (a) and HES (b) images of healthy colon over a 0.8 mm x 1 mm. Zooms SRH (c) and HES (d). Scale bares 100µm.


Barbara SARRI, Flora POIZAT, Cécile CADOR, Fabrice CAILLOL, Marc GIOVANNINI, Hervé RIGNEAULT (Marseille)
14:15 - 14:30 #16631 - CO07 Endoscopic Ultrasound (EUS)-guided single-step multiple gateway drainage of complex walled-off necrosis (WON) with lumen apposing metal stent (LAMS): a preliminary experience.
CO07 Endoscopic Ultrasound (EUS)-guided single-step multiple gateway drainage of complex walled-off necrosis (WON) with lumen apposing metal stent (LAMS): a preliminary experience.

Background EUS-guided drainage is suggested as the first approach in the management of symptomatic WON. A step-up method, including percutaneous drainage and mini-invasive surgery, is also proposed in case of either refractory or complex collections. Recently, a new LAMS with an integrated electrocautery delivery system (EC-LAMS) have been developed, facilitating drainage with its large lumen and wide flares. Although a single transluminal access is preferred, multiple step-up gateway technique is also proposed in case of multiple, large or low-responding WON.

Methods This is a retrospective analysis of prospective collected data of 5 consecutive patients (pts) with symptomatic complex WON, defined as large (>12 mm), septated or multiple, symptomatic collections, drained with a single-step, multiple gateway technique using EC-LAMS. Patients demographic, technical and clinical success, procedure time, necrosectomy sessions, further treatment needed, adverse events and post-procedure hospitalization were recorded and statistically analyzed.

Results Pancreatitis had biliary, alcoholic, post-traumatic, post-ERCP and idiopathic etiology. WON were located in the head-body of the pancreas (2/5 pts), in the body-tail (1/5 pts) and beside the whole pancreas (1/5 pts). WON were single with septa in 3 pts, multiple in 2 pts. 10 EC-LAMS were deployed with both transgastric and transduodenal approach (Table 1). Technical success was 100%. Procedure mean time for the deployment of two EC-LAMS was 29 min. Necrosectomy was completed in up to 3 sessions, if debris were still present, achieving clinical success in  3 cases (80%), with no recurrence in all the patients. One patient required a concomitant percutaneous drainage to yield healing and one required surgical necrosectomy. We reported one moderate bleeding, on the 1st post-operative day (POD), treated endoscopically and one severe bleeding, on 10th POD, requiring embolization. Both these adverse events seemed to be related to the endoscopic necrosectomy.

Conclusion Patients affected by multiple, septated, large WON can be considered “hard-to-treat-patients” and a single gateway could represent an insufficient treatment. Our case series showed that a single step multiple gateway technique using EC-LAMS is safe and feasible reducing number of endoscopic procedures and hospital stay. However further prospective, randomized, controlled studies are needed to define the long-term outcomes of this approach in complex WON.


Carlo FABBRI, Cecilia BINDA (Bologna, Italy), Emanuele DABIZZI, Marta FISCALETTI, Elio JOVINE, Vincenzo CENNAMO
La grande salle
14:30

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-9
14:30 - 16:00

Round table on Barrett's Esophagus

Moderators: Marc GIOVANNINI (Chef) (Marseille, France), Fauze MALUF-FILHO (sao Paulo, Brazil)
14:00 - 14:30 Why to treat a Barrett's Esophagus. Michel ROBASZKIEWICZ (Keynote Speaker, France)
14:30 - 15:00 Techniques of resection: EMR, ESD? Horst NEUHAUS (Keynote Speaker, Germany)
15:00 - 15:30 Techniques of ablation: RFA, Cryotherapy, Hybrid APC? Fabrice CAILLOL (Keynote Speaker, Marseille, France)
La grande salle
16:00

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-10
16:00 - 16:30

Conference: Metabolic endoscopy

Keynote Speaker: Marianna ARVANITAKI (Keynote Speaker, Belgium)
La grande salle
17:00

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-11
17:00 - 18:00

Free paper session

Moderators: Erwan BORIES (Marseille, France), Marc GIOVANNINI (Chef) (Marseille, France)
17:00 - 17:15 #16633 - CO08 Kystogastrostomy under echoendoscopic control in the drainage of pancreatic collections: Experience of a Moroccan service.
CO08 Kystogastrostomy under echoendoscopic control in the drainage of pancreatic collections: Experience of a Moroccan service.

Introduction: Pseudocyst pseudocysts are defined according to the Atlanta Consensus Conferenceas collections of pancreatic fluid surrounded by a tissue wallfibrous granules devoid of epithelium. Therapeutic options availablecurrently are surgical treatment, radiological drainage, and treatmentEndoscopic. The objective of our study is to evaluate the therapeutic results ofEndoscopic guided cystogastrostomy in the treatment of pseudocystspancreas and compare them with data from the literature. Materials and methods:This is a retrospective and descriptive study of patientswith symptomatic and persistent pancreatic pseudocysts after asix weeks. All these patients had benefited from a cystogastrostomyguided by endoscopic ultrasound using a linear echoendoscope and a cystotome. Aor several prostheses were then set up depending on the size of the collection andits content. Results: 23 patients underwent EUS-guided cystogastrostomy. Thesex ratio H / F was 1.5. Pseudocysts complicated acute pancreatitis in20 patients, pancreatic surgery in one patient and was post traumatic ina patient. The average age of the patients was 52.69 +/- 12.85 years. The average size ofpancreatic collections was 11.95 +/- 3.24cm. The technical success rate was95.65%. The complication rate was 4.5%. During an average follow-up of8.7 +/- 5.26 months, the therapeutic success rate was 90.9%. Two patients havepresented a clinical recurrence due to superinfection, and were bothtreated by surgery. The overall mortality rate was 4.35%. Conclusion: The results of our study confirm the efficacy and safety ofendoscopic guided cystograstrostomy in the first-line treatment ofpancreatic pseusocysts, and therefore invite us to use it whenever themeans permit.


Sara JAMAL (Rabat, Morocco), Hassan SEDDIK, Khaoula LOUBARIS, Ilhame EL KOTI, Ahmed BENKIRANE
17:15 - 17:30 #16609 - CO09 Endoscopic Ultrasound and Fine Needle Biopsy (EUS-FNB) in Chronic Pancreatitis: Differential Diagnosis between Pseudotumoral Masses and Pancreatic Cancer.
CO09 Endoscopic Ultrasound and Fine Needle Biopsy (EUS-FNB) in Chronic Pancreatitis: Differential Diagnosis between Pseudotumoral Masses and Pancreatic Cancer.

Introduction: EUS-FNA in the diagnosis of solid pancreatic tumors showed a high accuracy (from 79 to 92%). However, differential diagnosis between pseudotumoral masses and pancreatic neoplasms can be challenging in the setting of chronic pancreatitis (CP) and the reported EUS-FNA sensitivity for malignancy in parenchymal masses of patients with concurrent CP was inferior (from 59 to 73%). Aim and Methods: To evaluate the diagnostic accuracy of EUS-FNB in differentiating between inflammatory masses and malignancies in CP. We performed a retrospective analysis of prospectively maintained, multicentric, database. The study evaluated consecutive subjects undergoing EUS-FNB for pancreatic masses presenting clinical, radiological or endosonographic features of CP in accordance with Rosemont criteria. All procedures were performed using 20, 22 or 25 G core-needles (EchoTip®ProCore™). Final diagnoses were obtained from surgery or after at least 6 months of clinical and radiological follow-up. Results: 100 patients (59% males, mean age 62.4 yo + 9.4) met the inclusion criteria. Pancreatic lesions were located at: head (32%), neck (26%), tail (22%) and body (20%). EUS-FNB was performed by using a 20, 22 or 25-G needle in 5%, 38% and 57% respectively. An adequate histology sample was obtained in all cases. 53 lesions (53%) were finally considered as malignant and 47% as benign. Overall, a correct diagnosis was obtained in all but 7 cases [diagnostic accuracy 93% (95%IC 86.1%-97.1%), sensitivity 86.8% (95%IC 74.6%-94.5%), specificity 100% (95%CI 92.5%-100%), PPV 100%, NPV 87% (95%CI 77.1%-93.1%)]. We found that the 20-G needle had a diagnostic accuracy of 80% (95%CI 28.4%-99.5%); the 22-G needle showed a diagnostic accuracy of 92.1% (95%IC 78.6%-98.3%); the 25-G needle presented a diagnostic accuracy of 94.7% (95%IC 85.4%-98.9%). At binary logistic regression, only focal pancreatitis (OR 4.9; p<0.001), higher Ca19-9 (OR 2.3; p=0.02) and tail location of mass (OR 0.2; p<0.001) were independent factors associated with correct diagnosis. Gender, age, Rosemont criteria, mass size, number of passes and features at contrast harmonic EUS (CH-EUS) were not predictive of correct diagnosis. Conclusion: EUS-FNB is effective in the differential diagnosis between pseudotumoral masses and solid neoplasms in CP, showing a high diagnostic accuracy (93%). EUS-FNB should be considered the preferred diagnostic technique for diagnosing pancreatic cancer in the setting of CP.


Roberto GRASSIA, Nicola IMPERATORE, Pietro CAPONE, Fabrizio CEREATTI (Cremona, Italy), Edoardo FORTI, Filippo ANTONINI, Federico BUFFOLI, Germana DE NUCCI
17:30 - 17:45 #16636 - CO10 Endoscopic treatment of complications of hydatid cysts in the liverbroken in the bile ducts: Experience of a Moroccan service.
CO10 Endoscopic treatment of complications of hydatid cysts in the liverbroken in the bile ducts: Experience of a Moroccan service.

Introduction: The hydatid cyst of the liver (KHF) is a parasitic disease due to the development ofthe larval form of the taenia of the dog Echinococcus granulosus. By its clinical latency, theDiagnosis is most often at the stage of complications. Fistulization of the cysthydatid in the bile ducts is the most common complication.endoscopy is necessary because of the therapeutic problems and risks associated withsurgery. The objective of our study was to evaluate and analyze the effectiveness of ERCPin the diagnosis and treatment of hydatid cysts of the liver broken in the pathways ducts. Materials and methods: This is a 15-year retrospective and descriptive study, ranging from January 2002 toOctober 2017, focused on patients with fistulized KHF in the pathwaysBile. ERCP and endoscopic biliary sphincterotomy were performed in allpatients, 18 times preoperatively and 21 times postoperatively. Results: 39 patients with ruptured KHF in the biliary tract, 2.4% of the indicationsERCP in our series were included. The average age of patients was 47,with male predominance in 65% of cases. KHF broken in the waysgalls were complicated by persistent external biliary fistula postoperativelyin 34% of cases. Sphincterotomy was performed in all patients allowingremoval of hydatid material by extraction balloon or Dormia basket.The evolution was marked by the disappearance of jaundice after 5 to 12 days inaverage after endoscopic gesture and dryness of external biliary fistulaafter 10 to 12 days. Conclusion: The results of our study confirm the efficacy and safety of ERCP and theendoscopic sphincterotomy in biliary complications of echinococcosishepatic. It makes it possible to shorten the post-operative stay and to avoid areoperation, often difficult and haemorrhagic.


Sara JAMAL (Rabat, Morocco), Hassan SEDDIK, Khaoula LOUBARIS, Hanae BOUTALLAKA, Ahmed BENKIRANE
17:45 - 18:00 CO11 Post-Endosonography spontaneous pneumatic duodenal perforation of the periampullary diverticulum: A case report. Aliye SOYLU (PROF. DR.) (Free Paper Speaker, ISTANBUL, Turkey)
La grande salle
18:00

"Friday 28 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO28-12
18:00 - 18:30

Closing remarks and adjourn

Keynote Speaker: Marc GIOVANNINI (Chef) (Keynote Speaker, Marseille, France)
La grande salle
Saturday 29 September
08:30

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-13
08:30 - 10:30

SESSION 1 - Hands on (Golden Tulip Hôtel)
ERCP - Group 1

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-14
08:30 - 10:30

SESSION 1 - Hands on (Golden Tulip Hôtel)
ERCP - Group 2

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-15
08:30 - 10:30

SESSION 1 - Hands on (Golden Tulip Hôtel)
EUS-FNA - Group 1

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-16
08:30 - 10:30

SESSION 1 - Hands on (Golden Tulip Hôtel)
EUS-FNA - Group 2

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-17
08:30 - 10:30

SESSION 1 - Hands on (Golden Tulip Hôtel)
EUS-guided collection drainage - Group 1

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-18
08:30 - 10:30

SESSION 1 - Hands on (Golden Tulip Hôtel)
EUS-guided collection drainage - Group 2

11:00

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-19
11:00 - 13:00

SESSION 2 - Hands on (Golden Tulip Hôtel)
ERCP - Group 1

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-20
11:00 - 13:00

SESSION 2 - Hands on (Golden Tulip Hôtel)
ERCP - Group 2

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-21
11:00 - 13:00

SESSION 2 - Hands on (Golden Tulip Hôtel)
EUS-FNA - Group 1

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-22
11:00 - 13:00

SESSION 2 - Hands on (Golden Tulip Hôtel)
EUS-FNA - Group 2

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-23
11:00 - 13:00

SESSION 2 - Hands on (Golden Tulip Hôtel)
EUS-guided collection drainage - Group 1

"Saturday 29 September"

Added to your list of favorites
Deleted from your list of favorites
EUSENDO29-24
11:00 - 13:00

SESSION 2 - Hands on (Golden Tulip Hôtel)
EUS-guided collection drainage - Group 2

00:00
Added to your list of favorites
Deleted from your list of favorites
POSTER
00:00 - 00:00

POSTERS

00:00 - 00:00 #14740 - P01 Endoscopic Ultrasound in Pediatric population: a single tertiary-center experience.
Endoscopic Ultrasound in Pediatric population: a single tertiary-center experience.

Background and aim: The utility of endoscopic ultrasound (EUS) for the evaluation and management of gastrointestinal disorders among adults has been established. Data on efficacy of EUS in pediatric population (under 18 years of age) is limited. The aim of the work is to share the pediatric EUS experience at a single tertiary center. We describe the indications, findings, safety, success rate, and utility.

Patients and methods: All patients 18 years of age or younger referred for EUS between January 2016 and Jan 2018 were identified from our electronic medical record databases. Retrospective review of demographics data, procedure indications, EUS findings, and the clinical impact of EUS on the subsequent management of the patients was conducted.

Results: A total of 5 pediatric EUS were identified from 265 attempted procedures. The median age of the patients was 15.4 years (range 12–18 years), and 100% were females (5/5). The indications of EUS were: tracheal mass relation to esophagus before surgery (n=1), pancreatic head mass (n=1), retroperitoneal mass (n=1), ampullary mass (n=1), and localization of suspected insulinoma (n=1). EUS-FNA was done in 2 patients using 22G & 19G needles without any complications. The clinical impact of EUS on the subsequent management of the patients was as the following: the tracheal mass was separable from the esophagus and referred to surgery, the pancreatic head mass was diagnosed by FNA as carcinoid tumor confirmed by positive CD56 and Ki67 <2%, the retroperitoneal mass was diagnosed by FNA as Solid pseudopapillary neoplasm (SPN) and referred to surgery, the ampullary mass was duplication cyst and endoscopic deroofing was attempted without complication, and the suspected inslunioma was excluded in the last patient. 

Conclusion: EUS in pediatric population appears safe, feasible and impact the clinical decision of the subsequent management of the patients.  Increase in EUS awareness among pediatric gastroenterologists is expected in the next years and offering dedicated EUS training is indicated to some pediatric gastroenterologists. 


Ahmed ALTONBARY (Mansoura, Egypt), Hazem HAKIM, Wagdi ELKASHEF
00:00 - 00:00 #14741 - P02 Pancreatic head mass in patient with Situs Inversus Totalis: a challenging EUS examination and EUS-FNA.
Pancreatic head mass in patient with Situs Inversus Totalis: a challenging EUS examination and EUS-FNA.

Case: A 46 years man with Situs inversus totalis (SIT) was referred to our facility for endoscopic ultrasound (EUS) examination and fine needle aspiration (EUS-FNA) of pancreatic head mass with multiple liver focal lesions. With the patient in left lateral position; challenging EUS examination of the whole pancreas from the stomach starting from the pancreatic tail to the head, with anticlockwise rotation 90o  & a reversed orientation,  showed a hypoechoic pancreatic head mass 3.2x2.7 cm with multiple peri-pancreatic lymph nodes and multiple hyperechoic hepatic focal lesions. EUS-FNA was done from both pancreatic and hepatic masses by fanning technique using a 22G needle. Cytopathological examination revealed moderately differentiated adenocarcinoma with positive IHC for CK7 & CK19 consistent with metastatic tumor of pancreatic origin. Finally, patient started neoadjuvant therapy.     

Discussion: SIT is a rare congenital condition characterized by a mirror-image transposition of both the abdominal and thoracic viscera, its incidence accounts for 1/25,000 of the normal population [1]. This condition may cause difficulties in the diagnosis and therapeutic management of abdominal pathology [2,3]. The association of SIT and neoplasia is a rare coincidence; only sporadic cases have been reported. The first case was published by Maekawa in 1927; it was an autopsy case of gastric carcinoma in a 43-year-old man with SIT [4]. 

Conclusion: Herein, we describe a rare association of SIT and metastatic pancreatic adenocarcinoma. To the best of our knowledge, this is the first reported case of full EUS pancreatic examination and EUS-FNA in a patient with SIT.

References:

  1. 1. Lee SE, Kim HY, Jung SE, Lee SC, Park KW, Kim WK: Situs anomalies and gastrointestinal abnormalities. J Pediatr Surg 2006, 41(7):1237-1242. 
  2. 2. Uemura S, Maeda H, Munekage M, Yoshioka R, Okabayashi T, Hanazaki K: Hepatic resection for metastatic colon cancer in patients with situs inversus totalis complicated by multiple anomalies of the hepatobiliary system: the first case report. J Gastrointest Surg 2009, 13(9):1724-1727.
  3. 3. Blegen HM: Surgery in situs inversus. Ann Surg 1949, 129:244-259.
  4. 4. Maekawa T: Dextrocardia, report of five autopsy cases, with special reference to hereditary. Aichi Igakkai Zasshi 1927, 34:481–493.

Ahmed ALTONBARY (Mansoura, Egypt), Hazem HAKIM, Wagdi ELKASHEF
00:00 - 00:00 #16424 - P03 Cystic pancreatic lymphangioma - A rare pancreatic tumour.
Cystic pancreatic lymphangioma - A rare pancreatic tumour.

Pancreatic lymphangiomas are very rare benign neoplasms that should be differentiated from pseudocysts,  congenital cysts, cystic neoplasms especially mucinous and serous cystadenomas, solid pseudopapillary tumors, IPMN, acinar cell cyst adenocarcinoma and other retroperitoneal cystic tumours.  EUS and EUS-FNA with macroscopic examination of aspirated fluid, biochemical and cytological evaluation of the sample can accurately diagnose cystic lymphangiomas, hence avoid unnecessary workup or surgery. Here, we report a rare case of pancreatic lymphangioma in a 55 years old female complaining of persistent epigastric pain. Multi slice CT abdomen showed a multicystic pancreatic body lesion 3 x 4 cm with anechoic contents and thin delicate septa crisscrossing the lesion that were confirmed by endosonographic examination.  EUS-FNA revealed a milky white thick aspirate. The cyst fluid showed normal amylase, CEA and CA-19.9 but markedly elevated triglycerides, 3158 mg/dl. Cytopathological examination showed proteinaceous background with many epithelial cells and lymphocytes, no malignant cells. Based on EUS picture combined with high triglycerides level in cyst fluid, a diagnosis of pancreatic lymphangioma could be achieved with certainty. So, unnecessary workup or surgery can be avoided.


Hussein OKASHA, Mariam ZAGHLOUL (kafrelsheikh, Egypt), Hany KHATTAB
00:00 - 00:00 #16430 - P04 GASTRIC CARCINOID TUMOR: ABOUT 17 CASES.
GASTRIC CARCINOID TUMOR: ABOUT 17 CASES.

Background and aims: Carcinoid tumors are rare tumors, 1.5% of gastrointestinal tumors. Digestive Location represents 74% cases. They are tumors that grow slowly and remain localized for a long time (especially in the differentiated tumors). The clinical manifestations vary depending on tumor location and secretory character.

The aim of our study is to report 17 cases of Gastric Carcinoids (GCs) and describe the management procedures for patients with GCs.

Materials and Methods: 17 patients (7 males and 10 females) were diagnosed with gastric neuroendocrine tumors at our Center

The mean age was 47 years.

Results: for the clinical signs: abdominal pain was predominant: 64,7% of cases (Gastrointestinal bleeding: 11,7% of cases,  Melena: 10% of cases, Search for a primary cancer: 5,8% of cases and Anemia in 7,6% of cases). The type I was founded in 58,8% of cases and the type III in 32,2% cases. Multiple small polypoid fundic lesions represented 58,8% of the endoscopic appearance, 35% of ulcerative process, and 5,8% of cerebral fundic folds. The anatomo-pathological findings were consistent with carcinoid tumor of the stomach. Treatment consisted in endoscopic resection for the type I, total gastrectomy for the type II, and the metastatic spread was observed in 5.8% who received systemic chemotherapy.

Conclusions: The clinical approach to Gastric Carcinoids is largely dependent upon type and size of lesions, a lot of controversies still exist about the optimal treatment of GC tumors.


Youssef TOUIBI (meknes, Morocco), Fadoua ROUIBAA, Sara JAMAL, Aziz AOURARH
00:00 - 00:00 #16431 - P05 A rare entity of Pseudo-tumor autoimmune pancreatitis type 2: a case report.
A rare entity of Pseudo-tumor autoimmune pancreatitis type 2: a case report.

Autoimmune pancreatitis (AIP) is a rare disease, accounting for less than 2% of the causes of chronic pancreatitis. It is histologically characterized by the presence of lympho-plasmocytic infiltrate and diffuse pancreatic fibrosis. And divided into two forms: the type 1 so-called lympho-plasmocytic sclerosing AIP and the so-called ductocentric type 2 AIP.

Materials and methods:

This is a case of auto-immune pancreatitis pseudo-tumor, collected in our service in 2016.

Result:

A young man of 28 years, having presented for 10 days cholestatic jaundice rapidly progressive, evolving in a context of apyrexia and conservation of the general condition. Biology found significant cholestasis and cytolysis with normal IgG4 levels. Imaging showed significant dilatation of VBIH and VBP on diffuse hypertrophy of pseudo-tumoral pancreas without dilation of Wirsung. The diagnosis of AIP type 2 was retained, and the patient was put on corticotherapy based on 40 mg / day of prednisolone with progressive degeneration for a total duration of 14 weeks. The evolution was marked by a regression of jaundice and pruritus with complete normalization of the biological assessment at 3 weeks of treatment (13-month follow-up).

Conclusion:

Autoimmune pancreatitis remains a rare entity, whose diagnosis is difficult especially in its pseudo-tumoral form, and the response to corticosteroids is an integral part of the diagnostic criteria.


Youssef TOUIBI (meknes, Morocco), Said BELHAMIDI, Hicham KRIMO, Taoufik LAMSIAH
00:00 - 00:00 #16433 - P06 COLONOSCOPY IN THE DIAGNOSIS AND TREATMENT OF COLIC POLYPES IN ADULTS: ABOUT 78 CASES.
COLONOSCOPY IN THE DIAGNOSIS AND TREATMENT OF COLIC POLYPES IN ADULTS: ABOUT 78 CASES.

The recto-colic tumors are frequent and have an important place in the digestive tumoral pathology, imposing their early detection at the polyp stage, especially that the adenoma-cancer filiation is well established. The aim of this work is to specify the epidemiological, clinical, endoscopic and histological characteristics of these polyps.

Materials and methods :

This is a three-year extended retrospective study of 78 patients with colonic polyps out of a total of 452 colonoscopies performed during this period, for a hospital prevalence of 8.22%.

Results: The average age of patients is 50 years, with male predominance: 60 men for 18 women. The main indications are: rectorragies (36%), transit disorders (15%) and abdominal pain (20%). Polyps predominate in rectosigmoid in 63% of cases and in more than ¾ cases they are less than 10 mm in size. Resection of the polyps was performed in all cases, by the diathermic loop in 65 cases and by clamp in 13 cases.

Conclusion: In this study, the hospital prevalence of rectocolic polyps in Morocco is much lower than that reported in the literature for Western countries, but there is a similarity regarding the frequency of polyps in the recto-sigmoid. Endoscopic polypectomy and mucosectomy are the main therapeutic contributions of colonoscopy.


Youssef TOUIBI (meknes, Morocco), Said BELHAMIDI, Hicham KRIMO, Taoufik LAMSIAH
00:00 - 00:00 #16434 - P07 Ischemic colitis secondary to methotrexate: case report.
Ischemic colitis secondary to methotrexate: case report.

Ischemic colitis is the most common vascular pathology of the digestive tract. Its incidence is markedly increased, and is responsible for a significant morbidity and mortality, especially in the event of delayed diagnosis. The usual symptoms associating abdominal pain, diarrhea and rectal bleeding is very suggestive of the diagnosis, but atypical presentations are possible.Case: This is a case of ischemic colitis collected in our department.  A 53-year-old male with rheumatoid arthritis under methotrexate who had acute abdominal pain with rectal bleeding, colonoscopy showed non-gangrenous sigmoid involvement, the etiology of which was medicated (methotrexate). The clinical course was favorable after monitoring and the discontinuation of methotrexate.

Conclusion: Ischemic colitis is easily overlooked, any delay diagnosis increases the risk of mortality. Its clinical presentation is variable and the treatment depends on the severity of the lesions and the etiology.


Youssef TOUIBI (meknes, Morocco), Said BELHAMIDI, Hicham KRIMO, Taoufik LAMSIAH
00:00 - 00:00 #16435 - P08 evaluation of endoscopic rubber band ligation as a treatment for upper gastrointestinal bleeding by rupture of esophageal varices: experience of a Moroccan center.
evaluation of endoscopic rubber band ligation as a treatment for upper gastrointestinal bleeding by rupture of esophageal varices: experience of a Moroccan center.

Background and aims: Bleeding esophageal varices is the most serious complication of the portal hypertension, and the greater cause of dead (25% of the patients). The survival after esophageal varices bleeding depends in wide part from the swiftness and effectiveness of hemostasis and from the degree of functional liver reserve. The aim of our study is to report our experience about hemostasis bleeding esophageal varices with endoscopic rubber band ligation.

Methods: We assigned 50 patients (M: F ratio = 29:21; mean age was 47 years) with portal hypertension who were referred to our unit between April 2015 to April 2018 for endoscopic band ligation. Sessions of ligation were repeated every 4 to 6 weeks until the varices were eradicated

Results: Portal hypertension on cirrhosis was predominant (72% of cases with HVB/HCV-related cirrhosis, 4% alcoholic cirrhosis, 8 % primary biliary cirrhosis, and 16% cryptogenic cirrhosis). All patients received continuous intravenous drip of octreotide (250µg/h) during 3-5 days and non selective beta-blocker therapy after the episode. Primitive haemostasis was successfully achieved in 96% of patients. The varices have been obliterated in 68% of patients requiring a median of 3.8 (range 2-7) procedures, which is in good agreement with other published data. There was one case of death, following episodes of repetitive lightning haemorrhage.

Conclusions: Endoscopic rubber band ligation is currently considered the first-line treatment of proper multidisciplinary approach to the patient, both during the acute event than prevention of rebleeding, because it is an effective, safe and repeatable, in experienced hands.


Youssef TOUIBI (meknes, Morocco), Said BELHAMIDI, Hicham KRIMO, Sara JAMAL, Taoufik LAMSIAH
00:00 - 00:00 #16606 - P09 Role of EUS Elastography and FNA of second station lymph nodes in changing the plan of management of pancreatic and GI malignant lesions.
Role of EUS Elastography and FNA of second station lymph nodes in changing the plan of management of pancreatic and GI malignant lesions.

Abstract

Introduction: EUS plays an important role in local staging of pancreatic and gastrointestinal (GI) malignancy and lymph node metastasis including second station lymphadenopathy that may change the plan of management. Elastography adds valuable information to EUS by providing a qualitative and quantitative evaluation of tissue stiffness, thus reflecting the malignant or benign nature of the disease. Also, it is clinically useful in selecting the most suspicious LNs for tissue sampling, especially in patients presenting multiple LNs, thus reduces the number of unnecessary biopsies and can also help in guiding the puncture in the non-necrotic part of the suspicious LN.

Aim of work: This study aimed at assessing whether endosonographic elastography and EUS-FNA are able to improve LN staging and change the plan of management in patients with pancreatic and GI malignancy.

Patients and Methods: This cross sectional prospective study included 454 patients with malignant GI (248 patients) and pancreatic (206 patients) lesions sent for EUS staging and EUS-FNA from suspicious second station LNs if needed (lymph nodes with elasticity score 3 or 4 and/or strain ratio more than 2.5).

Results: We found suspicious second station lymphadenopathy in 25 out of 454 patients (5.5%) with GI and pancreatic malignant lesions, EUS-FNA proved metastatic lymphadenopathy in 16 out of them (64%), so we changed the plan of therapy in 3.5% of all examined patients (16/454). Out of 16 patients with metastatic second station lymphadenopathy, 4 patients with pancreatic adenocarcinoma became inoperable and referred for possible radio chemotherapy, and 12 patients with GI malignancy were referred for neoadjuvant chemotherapy to downstage the tumor for possible surgical intervention later on.

Conclusion: Careful EUS stating of pancreatic and GI malignant lesions especially second station lymphadenopathy with EUS-FNA of suspicious lymph nodes is mandatory as it defiantly changed the plan of management. 


Hussein OKASHA, Ahmed Ali GOMAA, Nancy ABDALLA, Abeer AWAD, Mohamed SALAH SHIHA (Caire, Egypt)
00:00 - 00:00 #16608 - P10 A Rare Case of Intraductal Papillary Mucinous Neoplasm of the Bile Duct.
A Rare Case of Intraductal Papillary Mucinous Neoplasm of the Bile Duct.

Intraductal papillary mucinous neoplasms (IPMNs) are mucin-producing papillary neoplasms of the pancreatic or biliary tract (BT-IPMN) that exhibit variable cellular atypia and cause ductal dilation. There are few reported cases of BT-IPMN in the literature. It has a higher propensity to undergo malignant transformation compared to pancreatic IPMN. We present an 80-year-old male complaining of painless jaundice. Abdominal CT revealed a 3.6 × 4.3 cm CHD soft tissue mass with diffuse dilatation of the left intrahepatic biliary ductal system and mild prominence of the right intrahepatic ductal system. EUS-FNA showed white viscous fluid with positive string sign, Histopathological examination revealed intraductal adenocarcinoma with positive mucin stain.  ERCP failed twice by two experts Endoscopist due to difficult papillary cannulation. Trial for biliary drainage by EUS was unsuccessful, due to difficulty to advance the wire through the left intrahepatic biliary ductal system distal to the CHD. A percutaneous rendezvous procedure enabled placement of guide wire through the left ductal system down to the papilla and deploying 10 French, 12 cm plastic stent.  


Ashraf ABOU-BAKR, Amr ABOU EL-MAGD (cairo, Egypt), Hussein OKASHA
00:00 - 00:00 #16612 - P11 Malignant transformation of an heterotopic pancreas: an uncommon finding.
Malignant transformation of an heterotopic pancreas: an uncommon finding.

Heterotopic pancreas (HP) is relatively common (autoptic incidence up to 13.7%), mostly located within 3-4 cm on both sides of the pylorus. It can be affected by any pancreatic disorder, including malignancy.

A 47 year-old man was referred for thickening of the gastric wall as documented on abdominal ultrasound. Upper endoscopy (EGD) described a broad based, apically ulcerated submucosal lesion of the antrum(a).

Endosonography (EUS-FNB) with fine needle biopsy (Procore 20G needle) confirmed the submucosal origin of a 30x40 mm hypoechoic not homogeneous lesion with irregular borders, involving both submucosal and muscularis propria, with invasion of perigastric tissues (Fig1a).

After EUS-FNB obtained confirmatory neoplastic tissue (a tissue micro-core shows malignant cells with marked nuclear enlarment-b), the patient underwent Whipple surgery. The surgical specimen revealed a pancreatobiliary-type ductal adenocarcinoma (G3) arising from an HP.

Among submucosal lesions, differential diagnoses include gastrointestinal stromal tumour, carcinoid, lymphoma and schwannoma. On endoscopy, an aspecific umbilicated submucosal lesion is usually described. EUS represents a pivotal diagnostic tool for characterization of the lesion and for tissue acquisition [4].

Malignant transformation in HP may be a challenging diagnosis and must be considered when a submucosal antral lesion with EUS worrisome characteristics (irregular borders, invasiveness, abnormal nodes and an irregular shape) is found.


Elia ARMELLINI (Italy, Italy), Marco BALLARÈ, Serena BATTISTA, Monica LEUTNER, Giulio DONATO, Gabriele GIUDICI, Marco ORSELLO, Pietro OCCHIPINTI
00:00 - 00:00 #16614 - P12 ROLE OF ENDOSONOGRAPHY IN THE UPPER GASTROINTESTINAL SUBEPITHELIAL LESION.
ROLE OF ENDOSONOGRAPHY IN THE UPPER GASTROINTESTINAL SUBEPITHELIAL LESION.

Introduction: Subepithelial lesions (SEL) are found incidentally during endoscopy. They are asymptomatic and often covered with normal mucosa. SEL is encountered in approximately 1 of every 500 endoscopy. Endosonography (EUS) is the most important diagnostic tool for optimal treatment and following for the SEL. In this study, we published the results of our clinic where patients underwent EUS and they were followed up for the SEL.

 Methods: The results of patients who underwent EUS procedure by using Olympus Linear / Radial echoendoscopy device are evaluated. All patients were recorded by sex, age, lesion site, size, layer, echo pattern, calcification, cystic cavities, and infiltration of serosa and lesion broad characteristics, EUS fine needle aspiration (FNA), and operations data found from medical records.

 Results: A total of 79 patients with preliminary SEL diagnosis were performed EUS. The mean age 52.9 ± 15.3, 38 (48.1%) were female and 41 (51.9%) were male patients were observed with an average of 16 months (3-22). Mean lesion size was 20.9 (6-90) mm. EUS-FNA was performed in 17(26.9%) of the patients. In the upper gastrointestinal system, the most common SEL encountered with EUS were first gastrointestinal stromal tumors (GIST) and second extraluminal compressions were seen in 16 (20.3%) of the patients (Table -1). When extraluminal compression is compared statistically according to the age and sex, there is not a significant difference (table-2). When divided according to the anatomical region, the most frequent lesions are in the esophagus leiomyoma (61.1%), GIST (58.5%) in the stomach and duodenum lipoma with 75% (table - 3).

 Conclusion: EUS for the description of layer, size, echo pattern and biopsy sampling in SEL is the most effective tool in the diagnosis and treatment decisions of SEL. According to the data we obtained from our clinic, the diagnosis and treatment is carried out effectively and easily when EUS/EUS FNA is effectively used for the patients who have SEL.


Aliye SOYLU (ISTANBUL, Turkey), Isa SEVINDIR, Hakan YILDIZ, Ilke SOYLU
00:00 - 00:00 #16615 - P13 Role of Endoscopic Ultrasound Elastography Strain Histograms and Ratio in the Evaluation of Patients with Pancreatic Masses, A Preliminary Study.
Role of Endoscopic Ultrasound Elastography Strain Histograms and Ratio in the Evaluation of Patients with Pancreatic Masses, A Preliminary Study.

The usefulness of endoscopic ultrasound (EUS) elastography has been reported for the diagnosis of pancreatic lesions. EUS quantitative elastography strain ratio (SR) and strain histograms (SHs) are recently developed methods for non-invasive differentiation of pancreatic masses. SHs is a quantitative technique based on artificial network processing of EUS elastography digitalized videos obtaining average value with a special computer program.

Aim of the work: To investigate the accuracy of SR and SHs EUS-based methods for the diagnostic differentiation of patients with pancreatic masses.

Patients and Methods: This preliminary prospective study included 50 patients with focal pancreatic masses. Elastography images were recorded using Pentax EG-3870 UTK EUS linear probes in combination with Hitachi Avius ultrasound machine. After the final diagnosis was established, the patients were divided into two groups: a pancreatic cancer group with positive cytology achieved by fine needle aspiration puncture or histology after surgery (31 patients), and a mass forming pancreatitis group with negative cytology and follow up for at least one year (19 patients).

RESULTS: Results were obtained with software for strain histograms with reversed hue scale (0 represents the hardest tissue structure and 255 the softest). Based on the receiver operating characteristics (ROC) curve coordinates, the cut-off point for Mode 1 was set at the value of 94. Values under the cut-off point indicated the presence of pancreatic malignancy. Mode 1 reached 80% sensitivity and 47% specificity with overall accuracy of 64% (95%CI: 36%-64%) in detection of  pancreatic malignant tumors among the patients with pancreatic masses. The positive and negative predictive values were 71% and 60%, respectively. The cut-off for the strain ratio was set at the value 3.6 based on the ROC curve coordinates. Values equal or above the cut-off value were indicative of pancreatic malignancy. The strain ratio reached 100% sensitivity, 58% specificity and an overall accuracy of 80% (95%CI: 50%-80%). The positive and negative predictive values were 80% and 100%, respectively.

 

CONCLUSION: Mode-1 SHs showed considerable sensitivity in pancreatic

malignant tumor detection but disappointingly has low specificity, these results may be improved with sequentially incorporating larger number of patients in this work . Higher sensitivity, specificity and accuracy were achieved using the strain ratio.


Hussein OKASHA, Ahmed MAGHRABY (Assiut, Egypt), Hussein EL-AMIN, Zain El-Abedeen SAYED
00:00 - 00:00 #16632 - P14 The place of endoscopic treatment in acute lithiasic cholangitis: About 105 cases in a Moroccan population.
The place of endoscopic treatment in acute lithiasic cholangitis: About 105 cases in a Moroccan population.

Introduction:Acute lithiasis cholangitis is a bacterial infection of the bile ducts due to a lithiasic obstacle. This is a therapeutic emergency that can be life-threatening. The purpose of our work is to evaluate the results of endoscopic drainage in case of acute lithiasis cholangitis.Materials and methods:This is a retrospective study conducted in the Department of Gastroenterology II of the Military Hospital Mohammed V Instruction of Rabat between April 2002 and December 2016 including 105 patients who received ERCP for acute cholangitis. We analyzed the epidemiological data of the patients, the results of the ERCP, as well as the endoscopic amorphity and post-sphincterotomy mortality. Results and Discussion: The mean age of the patients was 58 years old with extremes ranging from 21 to 80 years old and a sex ratio of 0.06. Endoscopic biliary sphincterotomy was performed in 91.4% of cases. A naso-biliary drain was put in place in 16.1% of cases. The overall success rate of stone extraction was 95.2%. The cure rate at 7 days after ERCP was 8.5%. The mortality rate was zero. Conclusion: Endoscopic sphincterotomy has revolutionized the treatment of the lithiasis of the main bile duct and lithiasic cholangitis. It allows a good biliary drainage. Its results are satisfactory, with less morbidity and mortality compared to surgical treatment.


Sara JAMAL (Rabat, Morocco), Hassan SEDDIK, Khaoula LOUBARIS, Ilhame EL KOTI, Ahmed BENKIRANE